✦ LIBER ✦

Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union

✍ Scribed by Pignatti, F.; Ehmann, F.; Hemmings, R.; Jonsson, B.; Nuebling, M.; Papaluca-Amati, M.; Posch, M.; Rasi, G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Approval probabilities and regulatory re

✍ Hartmann, Markus; Mayer-Nicolai, Christine; Pfaff, Otmar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Proposals for model-based paediatric med

✍ Efthymios Manolis; Gérard Pons 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Similarities and Differences in the Onco

✍ Senderowicz, A. M.; Pfaff, O. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 343 KB

Veterinary Toxicology || Regulatory aspe

✍ Anadón, Arturo 📂 Article 📅 2012 🏛 Elsevier ⚖ 599 KB

Emphasising the European Union's Commitm

✍ van de Loo, J.-W.; Trzaska, D.; Berkouk, K.; Vidal, M.; Draghia-Akli, R. 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 223 KB

PHP7 Orphan Drugs for Rare Diseases in t

✍ F. Catalá-López; S. Peiró; R. Gènova-Maleras; A. Garcia-Altés; G. Sanfélix-Gimen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB